Apheresis Market Size, Share, Industry Trends and Forecast to 2030

Apheresis Market Size & CAGR

The global Apheresis market size was valued at USD 2.5 billion in 2023, with a Compound Annual Growth Rate (CAGR) of 6.8% from 2023 to 2030. The market is expected to reach USD 4.3 billion by 2030, driven by increasing demand for blood component separation in various medical conditions such as autoimmune disorders, neurological diseases, and organ transplantation. The forecast growth rate indicates a steady rise in the adoption of apheresis procedures across different regions globally.

COVID-19 Impact on the Apheresis Market

The COVID-19 pandemic had a significant impact on the Apheresis market, leading to disruptions in supply chains, changes in healthcare delivery systems, and a surge in demand for blood products. The pandemic resulted in the cancellation of elective surgeries, leading to a decrease in the number of apheresis procedures performed. However, there was a growing need for convalescent plasma therapy for COVID-19 patients, driving the demand for apheresis procedures in certain regions. Healthcare providers had to adopt new strategies to ensure the safe implementation of apheresis procedures while managing the challenges posed by the pandemic.

Apheresis Market Dynamics

The Apheresis market is influenced by various factors, including technological advancements, increasing prevalence of chronic diseases, rising demand for blood components, and growing awareness about apheresis procedures. Key drivers of the market include the need for improved treatment outcomes in autoimmune disorders and cancer, advancements in apheresis technology, and the availability of skilled healthcare professionals. However, challenges such as high costs associated with apheresis procedures, limited reimbursement policies, and the complexity of procedures hinder market growth. Opportunities lie in the development of novel apheresis technologies, increasing research and development activities, and collaborations between key stakeholders in the healthcare industry.

Segments and Related Analysis of the Apheresis Market

The Apheresis market can be segmented based on product type, technology, application, and end-user. Product segments include plasmapheresis machines, photopheresis machines, and others. Technologies used in apheresis procedures include centrifugation, membrane filtration, and adsorption. Applications of apheresis procedures range from treatment of neurological disorders to organ transplantation and hematological disorders. End-users of apheresis services include hospitals, blood banks, and specialty clinics.

Apheresis Market Analysis Report by Region

Asia Pacific Apheresis Market Report

The Asia Pacific region is expected to witness significant growth in the Apheresis market due to increasing healthcare expenditure, growing prevalence of chronic diseases, and advancements in apheresis technology. Countries like China, Japan, and India are driving market expansion with the adoption of innovative apheresis procedures and the presence of key market players in the region. Rising awareness about blood component therapies and an increasing number of apheresis centers contribute to market growth in Asia Pacific.

South America Apheresis Market Report

South America represents a developing market for apheresis procedures, with Brazil leading in terms of market share. The region is witnessing a rise in the prevalence of autoimmune disorders, hematological diseases, and organ failures, driving the demand for apheresis services. The adoption of novel technologies and the expansion of healthcare infrastructure are contributing to the growth of the Apheresis market in South America.

North America Apheresis Market Report

North America dominates the Apheresis market, with the United States being a key revenue generator. The region has a well-established healthcare system, high healthcare expenditure, and a strong focus on research and development in apheresis technology. The presence of prominent market players, favorable reimbursement policies, and increasing prevalence of chronic diseases support market growth in North America.

Europe Apheresis Market Report

Europe is a mature market for apheresis procedures, with countries like Germany, France, and the United Kingdom leading in terms of market share. The region has a high adoption rate of apheresis technologies, advanced healthcare infrastructure, and robust regulatory framework supporting the safe implementation of apheresis procedures. Increasing awareness about blood component therapies and the rising burden of chronic diseases drive market growth in Europe.

Middle East and Africa Apheresis Market Report

The Middle East and Africa region are witnessing steady growth in the Apheresis market, with countries like Saudi Arabia, UAE, and South Africa emerging as key markets. The increasing prevalence of hematological disorders, advances in apheresis technology, and the expansion of healthcare facilities contribute to market growth in the region. Limited access to apheresis services in certain areas presents opportunities for market expansion in the Middle East and Africa.

Apheresis Market Analysis Report by Technology

The Apheresis market can be analyzed based on the technology used in procedures, including centrifugation, membrane filtration, and adsorption. Centrifugation is the most commonly used technology in apheresis procedures, involving the separation of blood components based on density. Membrane filtration utilizes semi-permeable membranes to separate plasma from cellular components. Adsorption technology involves the removal of specific substances from the blood using adsorbent materials. Each technology offers unique advantages and applications in apheresis procedures, catering to different patient needs and medical conditions.

Apheresis Market Analysis Report by Product

The Apheresis market can be segmented based on product types such as plasmapheresis machines, photopheresis machines, and others. Plasmapheresis machines are widely used for plasma exchange procedures in conditions like autoimmune disorders and renal diseases. Photopheresis machines are specialized devices used for extracorporeal photopheresis to treat skin disorders and graft-versus-host disease. Other apheresis products include leukapheresis machines, erythrocytapheresis machines, and plateletpheresis machines, each designed for specific therapeutic purposes.

Apheresis Market Analysis Report by Application

The Apheresis market application segment covers a wide range of medical conditions and therapeutic interventions, including autoimmune disorders, neurological diseases, hematological disorders, organ transplantation, and oncology. Apheresis procedures are used in the treatment of conditions like multiple sclerosis, myasthenia gravis, sickle cell disease, and acute liver failure. The application of apheresis therapies continues to expand as new indications are discovered, and advancements in technology enable more precise and effective treatment strategies.

Apheresis Market Analysis Report by End-User

The Apheresis market caters to a diverse range of end-users, including hospitals, blood banks, specialty clinics, and research institutes. Hospitals are the primary users of apheresis services, offering comprehensive medical care and specialized treatment to patients requiring blood component separation. Blood banks play a crucial role in collecting, processing, and distributing blood products for transfusion and apheresis procedures. Specialty clinics focus on specific medical conditions and provide targeted apheresis therapies for patients with autoimmune disorders, hematological diseases, and organ failures.

Key Growth Drivers and Key Market Players of Apheresis Market and Competitive Landscape

The Apheresis market is driven by key growth drivers such as increasing prevalence of chronic diseases, advancements in apheresis technology, rising demand for blood component separation, and growing awareness about therapeutic apheresis procedures. Key market players in the Apheresis market include:

• Terumo BCT, Inc.
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• Braun Melsungen AG
• Kaneka Corporation
• Asahi Kasei Corporation
• Medica S.p.A.

These companies are at the forefront of developing innovative apheresis technologies, expanding their product portfolios, and collaborating with healthcare providers to deliver high-quality apheresis services to patients globally. The competitive landscape of the Apheresis market is characterized by strategic partnerships, mergers and acquisitions, product launches, and investments in research and development to drive market growth and sustain competitive advantage.

Apheresis Market Trends and Future Forecast

The Apheresis market is witnessing several trends that are shaping the future of therapeutic apheresis procedures. Key trends include the adoption of next-generation apheresis technologies, personalized treatment strategies based on patient profiles, increasing applications of apheresis in rare diseases and genetic disorders, and the integration of artificial intelligence and machine learning in apheresis systems. The future forecast for the Apheresis market involves continued innovation, research, and collaboration among key stakeholders to enhance patient outcomes, improve treatment efficacy, and expand the scope of apheresis therapies in various medical specialties.

Recent Happenings in the Apheresis Market

The Apheresis market has been witnessing notable developments and events that impact market dynamics and growth prospects. Some recent happenings in the Apheresis market include:

• Terumo BCT, Inc. announced a collaboration with a leading research institute to conduct clinical trials on a novel apheresis technology for immune system disorders.
• Fresenius SE & Co. KGaA launched a new plasmapheresis machine with improved safety features and enhanced user interface for healthcare providers.
• Haemonetics Corporation acquired a smaller apheresis device manufacturer to expand its product portfolio and strengthen its market presence in key regions.

These recent developments highlight the dynamic nature of the Apheresis market, with companies investing in research, innovation, and strategic collaborations to drive market growth and meet the evolving needs of patients and healthcare providers in the evolving healthcare landscape.